| Company type | Public |
|---|---|
| LSE: SYNC FTSE 250 component | |
| Founded | 2012; 14 years ago (2012) |
| Headquarters | , |
Key people | Melanie Gee (chair) |
| Website | www |
Syncona (LSE: SYNC) is a largeBritish closed-endedinvestment trust dedicated to life science investments. Co-founded as Syncona Partners in 2012 by former CEO Martin Murphy and the Wellcome Trust,[1] before merging with the Battle Against Cancer Investment Trust ('BACIT') in December 2016 and listing publicly,[2] the company is listed on theLondon Stock Exchange and is a constituent of theFTSE 250 Index.[3] Its Chair is Melanie Gee.[4]